Wird geladen...
A Prospective, Open-Label Trial of Clevidipine for Controlled Hypotension During Posterior Spinal Fusion
OBJECTIVES: Controlled hypotension is one means to limit or avoid the need for allogeneic blood products. Clevidipine is a short-acting, intravenous calcium channel antagonist with a half-life of 1 to 3 minutes due to rapid metabolism by non-specific blood and tissue esterases. To date, there are no...
Gespeichert in:
| Veröffentlicht in: | J Pediatr Pharmacol Ther |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Pediatric Pharmacy Advocacy Group
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4353201/ https://ncbi.nlm.nih.gov/pubmed/25859171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-20.1.54 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|